Advances in the treatment of hemorrhagic stroke: A possible new treatment

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.